ACTL8

Across TCGA pan-cancer cohorts, ACTL8 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ACTL8 data layer compared with 24 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher ACTL8 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated ACTL8 expression acts as an unfavorable survival marker.

UCEC and LSCC are the cancer types where ACTL8 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	DFS	Median	All	0.736	1.000	.009	6	view →
LSCC	OS	Median	All	0.614	1.000	.045	1	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

ACTL8–UCEC (DFS)

Open the UCEC breakdown →